Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight ...

At the conference, AstraZeneca and Daiichi Sankyo will present their case for Dato-DXd in NSCLC, while BioNTech and Merus ...

As an update to data reported at the EORTC-NCI-AACR (ENA) conference in October 2024, the company shared a new analysis of safety and activity data from the July 23, 2024 data cutoff date in patients ...